Beranda › Infeksi Virus › Maryland
Uji klinis Infeksi Virus di Maryland
14 studi untuk Infeksi Virus mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01011712A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- University of Maryland, Baltimore
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07654283Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
6 Months – 120 Years · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
2 Months – 115 Years · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT04419870Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 1 hingga 120 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT00032513Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Johns Hopkins, Baltimore
Menerima pesertaFase 1/2
1 Month – 79 Years · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04197596Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Johns Hopkins University, Baltimore
- National Institutes of Health (NIH), Bethesda
Menerima pesertaFase 1
3 Months – 80 Years · Semua jenis kelamin · Diperbarui 26 Jan 2026 · NCT04691622Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
Menerima pesertaFase 1/2
Semua usia · Semua jenis kelamin · Diperbarui 19 Feb 2025 · NCT04790240Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.